Your session is about to expire
← Back to Search
Aspirin for Cancer (ACES Trial)
ACES Trial Summary
This trial will study the effect of aspirin on cancer and mortality rates.
ACES Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowACES Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ACES Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I need help with daily activities like bathing or dressing.I have a history of heart problems.I have a condition that puts me at high risk for serious bleeding.I am a Caucasian aged 70 or older, eligible at certain US locations.I am 65 or older and identify as African American or Hispanic.I am 70 years or older and live in Australia.
- Group 1: Aspirin
- Group 2: Placebo
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available opportunities to participate in this research?
"This trial is no longer recruiting participants. It first went live on September 1st 2013 and was last updated April 2nd 2021. However, there are currently 486 clinical trials for malignancies actively enrolling patients and 168 studies examining the effects of Aspirin that require volunteers."
Has the FDA given its stamp of approval to Aspirin?
"Our team at Power gave Aspirin a rating of 3, as we are currently in Phase 4 of this trial; meaning it has been authorised for use."
Is this experimental procedure pioneering in the healthcare field?
"Primarily researched since 2005, the initial trial for Aspirin was sponsored by Abbott and involved 15480 participants. Consequently, this drug has achieved Phase 4 approval status in recent years with 168 ongoing studies conducted across 1398 cities and 57 countries worldwide."
What purpose does Aspirin typically serve?
"Aspirin is most commonly prescribed to treat percutaneous coronary intervention (PCI) but can also be used for dental procedures, inflammation, and neck pain."
What other research projects have utilized Aspirin as an experimental treatment?
"Initially investigated in 2005 by Clinical Trial Service Unit, NDPH at the University of Oxford, aspirin has since been subject to 18,769 completed trials. Currently 168 active studies are being carried out across the globe but particularly from Detroit, Michigan."
What is the maximal amount of participants being accepted into this experiment?
"Unfortunately, the recruitment period for this trial has come to a close. It was posted on September 1st 2013 and last edited April 2nd 2021. However, there are still 486 trials targeting malignancies that have active recruiment periods as well as 168 studies concerning Aspirin actively seeking patients."
In what areas can this investigation be accessed?
"Wayne State University in Detroit, Queens Cancer Medical Center in Queens, and Regional Academic Health Center in Harlingen are among the 40 medical centres enrolled to assist with this trial."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger